TauRx Therapeutics

Infobox Company
name = TauRx Therapeutics

type = Public
genre =
foundation = Singapore (2002) flagicon|Singapore
founder = Professor Claude Wischik
Dr K. M. Seng
location_city =
location_country =
location = Singapore flagicon|Singapore
locations =
area_served =
key_people = Professor Claude Wischik, Executive Chairman
Dr Shay Way Seng, Managing Director
John Harry, Lead Pharmaceutical Strategist
industry = Pharmaceuticals
products =
services =
market c

revenue =
operating_income =
net_income =
assets =
equity =
owner =
num_employees =
parent =
divisions =
subsid =
homepage = [http://www.taurx.com/ TauRx Therapeutics]
footnotes =
intl = yes

TauRx Therapeutics Ltd is a startup pharmaceutical company that is based in Singapore. [cite web
last=Marchione
first= Marilynn
title= Experimental Alzheimer's drug shows early promise
publisher= Associated Press
date= 2008-07-30
url= http://ap.google.com/article/ALeqM5jK3o2IH-4QHTz4i5e9OlzzFCA2pgD927P6QO0
accessdate= 2008-07-31 ]

The company was founded in 2002 by the late gynecologist, surgeon and venture capitalist K. M. Seng and the research biologist Claude Wischik who is currently its CEO.

In 1988 Wischik and coworkers discovered that abnormal fibres of tau protein form inside nerve cells in patients with Alzheimer disease, and that their aggregation correlatates to the development of dementia. The company has focused on the development of drugs that dissolve tau fibres in an attempt to manage patients with Alzheimer. rember is an investigational drug for this purpose by TauRx Therapeutics. [cite web
last= Wilkinson
first= Emma
title= Alzheimer's drug 'halts' decline
publisher= BBC
date= 2006-07-29
url= http://news.bbc.co.uk/2/hi/health/7525115.stm BBC news
accessdate= 2008-07-29]

References

External links

* [http://www.taurx.com Official site]